[Betamethasone in the treatment of acute lymphatic leukosis and other lymphoproliferative diseases].
作者信息
Invernizzi R
出版信息
Minerva Med. 1980 Nov 10;71(44):3247-50.
PMID:6935535
Abstract
Personal experience with the use of betamethasone, used orally in associated with various cytostatic drugs for inducing remission in acute lymphatic leucosis and some cases of lymphoproliferative disease is reported. The results obtained point to the effectiveness and tolerance of the drug, even in the high doses that are required to treat such blood diseases.
摘要
相似文献
1
[Betamethasone in the treatment of acute lymphatic leukosis and other lymphoproliferative diseases].
Minerva Med. 1980 Nov 10;71(44):3247-50.
2
[The use of betamethasone in polychemotherapy of lymphoproliferative diseases].[倍他米松在淋巴增殖性疾病多药化疗中的应用]
Minerva Med. 1980 Sep 8;71(32):2293-7.
3
4
[Betamethasone phosphate in hematology].[血液学中的倍他米松磷酸酯]
Lille Med. 1971 Apr;16:S 2:625-30.
5
[Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].[多药联合治疗淋巴增生性疾病的疗效]
Haematologica. 1970;55(7):465-70.
6
[Leurosine, the 3d alkaloid from Vinca rosea, in the treatmen t of Hodgkin's disease, acute lymphoblastic leukemia and lymphoblastosarcoma].
Sem Hop. 1966 Nov 26;42(49):2952-4.
7
[On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].[关于甲基肼类细胞抑制剂对恶性成血细胞肿瘤的作用]
Wien Med Wochenschr. 1966 May 21;116(21):468-71.
8
[Modern aspects of treatment of acute leukemia].
Vestn Akad Med Nauk SSSR. 1968;23(4):21-5.
9
[Trial treatment of acute leukemia and Hodgkin's disease with rubidomycin (or daunomycin) alone or in combination].
Sem Hop. 1967 Jul 20;43(32):2108-14.
10
Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.成年淋巴增生性疾病患者亚甲基四氢叶酸还原酶C677T基因多态性及其对化疗的影响
Ann Hematol. 2006 Dec;85(12):863-8. doi: 10.1007/s00277-006-0175-4. Epub 2006 Aug 31.
Zotero 插件